Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in RPRX — Royalty Pharma plc

CIK 1167557 Greenwich, CT
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$241,404,446
+$59,980,089 QoQ
Shares Held
4,305,412
+13.8% QoQ
Ownership
0.749%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#16
of 646 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. RPRX ranks #8 (4.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
This page 		4,305,412 $241,404,446

All Filings in RPRX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $241,404,446 4,305,412
2026-03-31 $181,424,357 3,782,038
2025-12-31 $99,059,587 2,563,654
2025-09-30 $69,187,112 1,961,086
2025-06-30 $62,557,987 1,736,275
2025-03-31 $81,189,837 2,608,090
2024-12-31 $48,562,771 1,903,676
2024-09-30 $18,764,529 663,292
2024-06-30 $20,715,400 785,567
2024-03-31 $14,120,865 464,961
2023-12-31 $12,105,694 430,961
2023-09-30 $17,252,436 635,683
2023-06-30 $5,765,471 187,556